Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses - Summary of Investments (Details)

v2.4.1.9
Acquisitions, Investments, and Licenses - Summary of Investments (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Long-term Investments [Abstract]    
Equity method investments $ 9,400opk_EquityMethodInvestmentExcludingVariableInterestEntity  
Equity Method Investment, Underlying Equity in Net Assets 30,787us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets  
Variable interest entity, equity method 981opk_EquityMethodInvestmentVariableInterestEntity  
Available for sale investments 5,758us-gaap_AvailableForSaleSecuritiesNoncurrent  
Warrants and options 6,314opk_StockOptionandWarrantInvestments  
Total carrying value of investments $ 22,453us-gaap_LongTermInvestments [1] $ 30,653us-gaap_LongTermInvestments [1]
[1] As of December 31, 2014 and December 31, 2013, total assets include $7.6 million and $6.7 million, respectively, and total liabilities include $12.1 million and $10.4 million, respectively, related to SciVac, previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 4.